Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D3OX
|
||||
Former ID |
DNC005460
|
||||
Drug Name |
N-[5-(2-Nitro-phenyl)-furan-2-carbonyl]-guanidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527509] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H10N4O4
|
||||
Canonical SMILES |
C1=CC=C(C(=C1)C2=CC=C(O2)C(=O)N=C(N)N)[N+](=O)[O-]
|
||||
InChI |
1S/C12H10N4O4/c13-12(14)15-11(17)10-6-5-9(20-10)7-3-1-2-4-8(7)16(18)19/h1-6H,(H4,13,14,15,17)
|
||||
InChIKey |
KLPHIGVDYLBNDU-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium/hydrogen exchanger 1 | Target Info | Inhibitor | [527509] | |
Pathway Interaction Database | Endothelins | ||||
RhoA signaling pathway | |||||
ErbB1 downstream signaling | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
Reactome | Hyaluronan uptake and degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.